Related Experiment Video
Updated: Sep 3, 2025
08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.9K
Lethal encephalitis in a pediatric patient with SARS-CoV-2.
Sevgi Yimenicioğlu1, Kazım Zararcı2, Ali Murat Aynacı3
1Departments of Pediatric Neurology, Health Ministry Eskisehir City Hospital, Eskişehir, Turkey.
The Turkish Journal of Pediatrics
|July 28, 2022
Summary
This case study highlights a rare, severe presentation of encephalitis in a 15-year-old following a prior mild COVID-19 infection. The study underscores the potential for devastating neurological sequelae from SARS-CoV-2, even after initial recovery.
Area of Science:
- Neurology
- Infectious Diseases
- Virology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily impacts the respiratory system.
- Neurological disorders have been anecdotally linked to SARS-CoV-2 infections.
- Encephalitis as a complication of COVID-19 remains poorly understood despite increasing reports.
Observation:
- A rare case of fulminant encephalitis in a 15-year-old male is presented.
- The patient experienced a severe neurological course five months after a mild SARS-CoV-2 infection with no prior sequelae.
- Despite medical intervention, the patient's condition deteriorated significantly.
Findings:
- This case exemplifies a severe central nervous system manifestation of SARS-CoV-2 infection.
- The findings suggest a potential for delayed and severe neurological complications following even mild COVID-19.
- The pathophysiology of SARS-CoV-2-induced encephalitis requires further investigation.
Implications:
- Highlights the critical need for recognizing and managing neurological complications of COVID-19.
- Emphasizes the importance of continued research into the long-term neurological effects of SARS-CoV-2.
- Informs clinical practice regarding potential severe outcomes in pediatric patients post-COVID-19.
